...peptides to treat thrombosis. The patent is one in a series licensed exclusively to IART's Telios Pharmaceuticals Inc....

...received 510(k) clearance by FDA as a device in 1996 as a hydrating wound dressing. Telios...

...ATIS's Dermagraft engineered skin is still in trials for diabetic ulcers, while products such as Telios Pharmaceuticals Inc....

...peptide sequence arginine-glycine-aspartic acid (RGD) to treat thrombosis. The patent is licensed exclusively to IART's Telios Pharmaceuticals Inc....

...IART subsidiary Telios Pharmaceuticals Inc. (San Diego, Calif.) received a $96,500 grant from the National Cancer Institute to...

...the technology to enhance wound healing, has an exclusive license to the patent through its Telios Pharmaceuticals Inc....

...1/18/93 - 63% Cortech Inc. (CRTQ) Bradycor Systemic inflammatory response syndrome (SIRS) 7/21/94 - 63% Telios Pharmaceuticals Inc....

...52 percent) on the week. The scenario recalls Telios Pharmaceuticals' financing dilemma in late 1994. Telios...
...shares it had closed on two weeks prior. The tender offer ultimately was withdrawn, and Telios...

...IART's Telios Pharmaceuticals subsidiary filed a patent infringement suit in the U.S. District Court for the...

...of working capital, and the landscape around it was littered with failures in related fields: Telios...